Inflammation blocked by tomato in the obese

7 May 2009

Tomato products may protect against inflammation, according to data from a recent multicenter, randomized, controlled trial. The team of US  researchers who conducted the study also found that processed tomato  products had a beneficial effect on vasodilatation and inflammatory  mediator C-reactive protein in overweight and obese subjects.

Within the diets of 56 healthy volunteers who took part in the study,  processed tomato products or non-tomato products were matched in  calories, sodium and sugar content. All of the test subjects consumed a  low-tomato diet for three weeks followed by either a six-week  high-tomato diet or low-tomato diet. At six weeks, the subjects were  assessed as to the response of tomato after eating a high-fat meal.  Compared with the low-tomato group, the high-tomato arm experienced a  C-reactive protein level that was lower in response to the high-fat  meal. High-tomato intake was also associated with increased mean vessel  diameter, but flow mediated vasodilatation was not different, possibly  related to the Body Mass Index of subjects.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight